Publications by authors named "Harald Dinter"

Claim this Profile
N
Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors.
Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier, Harald Dinter

Clin Cancer Drugs· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic somatic cell therapy: process development challenges and future opportunities.
Farah S Fawaz, Terry W Hermiston, Harald Dinter

Curr Opin Mol Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent triazolothione inhibitor of heat-shock protein-90.
Richard I Feldman, Bob Mintzer, Daguang Zhu, James M Wu, Sandra L Biroc, Harald Dinter

Chem Biol Drug Des· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tomoregulin internalization confers selective cytotoxicity of immunotoxins on prostate cancer cells.
Xiao-Yan Zhao, Hsiao-Lai Liu, Bing Liu, Joerg Willuda, Gerhard Siemeister, Harald Dinter

Transl Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.
Donato Tedesco, Jianhuan Zhang, Lan Trinh, Guita Lalehzadeh, Rene Meisner, Harald Dinter

Neoplasia· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Han Ying, Sandra L Biroc, Wei-Wei Li, Bruno Alicke, Jian-Ai Xuan, Harald Dinter

Mol Cancer Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Jian-Ai Xuan, Doug Schneider, Pam Toy, Rick Lin, Alicia Newton, Harald Dinter

Cancer Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.
Arndt J Schottelius, Harald Dinter

Cancer Treat Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Renate Parry, Doug Schneider, Debra Hudson, Debbie Parkes, Jian-Ai Xuan, Harald Dinter

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.
Deborah A Zajchowski, Sandra L Biroc, Hsaio-Lai Liu, Steven K Chesney, Jens Hoffmann, Harald Dinter

Int J Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.
Richard I Feldman, James M Wu, Mark A Polokoff, Monica J Kochanny, Harald Dinter

J Biol Chem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tomoregulin for radioimmunotherapy of prostate cancer.
Xiao-Yan Zhao, Doug Schneider, Sandra L Biroc, Renate Parry, Bruno Alicke, Harald Dinter

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis